US equities
|
NVDA
$152.08
▼-2.17%
MU
$701.97
▼-1.47%
AMD
$514.45
▲+2.19%
SPCX
$144.35
▲+1.87%
SNDK
$777.23
▼-2.51%
TSLA
$384.10
▲+1.05%
AAPL
$353.47
▲+0.44%
AMZN
$266.17
▲+3.21%
NVDA
$152.08
▼-2.17%
MU
$701.97
▼-1.47%
AMD
$514.45
▲+2.19%
SPCX
$144.35
▲+1.87%
SNDK
$777.23
▼-2.51%
TSLA
$384.10
▲+1.05%
AAPL
$353.47
▲+0.44%
AMZN
$266.17
▲+3.21%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Keith J/Sullivan
Recent news which mentions Keith J/Sullivan
Lab Notes: FDA approves Incyte's vitiligo treatment; Neuronetics gets a 'big win'
July 22, 2022
Tickers
INNO
Tags
Pharmaceuticals
Hervé Hoppenot
Zynerba Pharmaceuticals Inc/
From
Business Journals